ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bohnet, S
Right arrow Articles by Dalhoff, K
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bohnet, S
Right arrow Articles by Dalhoff, K
Eur Respir J 1994; 7: 229-234
Copyright © ERS Journals Ltd 1994

Original Articles

Intercellular adhesion molecule-1 (ICAM-1) is upregulated on alveolar macrophages from AIDS patients

S Bohnet, J Braun, and K Dalhoff

In acquired immune deficiency syndrome (AIDS) patients, alveolar macrophages (AMs) have an increased ability to serve as accessory cells during the generation of an immune response. In addition to soluble mediators, like cytokines, molecules of the major histocompatibility complex (MHC) class II and adhesion molecules, like intercellular adhesion molecule-1 (ICAM-1), play a major role in the regulation of these cellular interactions. Using an enzyme-linked immunosorbent assay (ELISA) technique and immunocytochemical staining, we investigated ICAM-1 and human leucocyte antigen-DR (HLA-DR) expression on AMs from 20 AIDS (HIV+) patients in context with other parameters of macrophage activation, such as tumour necrosis factor-alpha (TNF-alpha) secretion and the release of superoxide anion, comparing the results to a group of healthy volunteers. In addition, we quantified soluble ICAM-1 in the bronchoalveolar lavage fluid (BALF) using a commercially available kit. We found a nearly twofold increase in ICAM-1 expression (0.81 +/- 0.30 (SD) versus 0.42 +/- 0.12 ELISA units (EU) (mean +/- SD)), whilst the number of HLA-DR+ AMs was slightly decreased in AIDS-patients (80 +/- 5 versus 89 +/- 3%). Furthermore, soluble ICAM-1 in the BALF of these patients was significantly increased (41.9 +/- 26.1 versus 19.1 +/- 5.1 ng.ml-1). ICAM-1 levels on AMs in the patient group correlated strongly with the sodium fluoride triggered release of superoxide anion (O2-) but not with the spontaneous secretion of TNF-alpha by AMs.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
 CVIHome page
N. V. Sipsas and P. P. Sfikakis
Expanding Role of Circulating Adhesion Molecules in Assessing Prognosis and Treatment Response in Human Immunodeficiency Virus Infection
Clin. Vaccine Immunol., November 1, 2004; 11(6): 996 - 1001.
[Full Text] [PDF]

Home page
 J Med MicrobiolHome page
A.J. CANT, S.B. GORDON, R.C. READ, C.A. HART, and C. WINSTANLEY
Respiratory infections: Proceedings of the Eighth Liverpool Tropical School Bayer Symposium of Microbial Disease held on 3 February 2001
J. Med. Microbiol., November 1, 2002; 51(11): 903 - 914.
[Full Text] [PDF]

Home page
 Br Med BullHome page
S B Gordon and R C Read
Macrophage defences against respiratory tract infections: The immunology of childhood respiratory infections
Br. Med. Bull., March 1, 2002; 61(1): 45 - 61.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. L. Yu and A. H. Limper
Pneumocystis carinii induces ICAM-1 expression in lung epithelial cells through a TNF-alpha -mediated mechanism
Am J Physiol Lung Cell Mol Physiol, December 1, 1997; 273(6): L1103 - L1111.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by the European Respiratory Society.